To receive the ACTION Registry–GWTG Gold Performance Achievement Award, Lowell General Hospital consistently followed the treatment guidelines in ACTION Registry–GWTG for 8 consecutive quarters and met a performance standard of 85% for specific performance measures. Following these treatment guidelines improves adherence to ACC/AHA Clinical Guideline recommendations, monitors drug safety and the overall quality of care provided to cardiac patients.
“The American College of Cardiology Foundation and the American Heart Association commend Lowell General Hospital for its success in implementing standards of care and protocols. The full implementation of acute and secondary prevention guideline-recommended therapy is a critical step in saving the lives and improving outcomes of heart attack patients,” Gregg C. Fonarow, MD, FACC, FAHA, ACTION Registry-GWTG Steering Committee Chair and Director of Ahmanson-UCLA Cardiomyopathy Center and James Jollis, MD, FACC, ACTION Registry-GWTG Co-Chair and Professor of Medicine and Radiology at Duke University Hospital.
“Our staff is keenly focused on providing clinical care that meets the highest standards of quality. We are fortunate to have an experienced cardiology team that is committed to long-term success for our patients,” said Patricia Morse, RN, Director of Cardiology Services. “Providing the community with access to outstanding cardiac care, along with education to reduce the risks for heart disease, is critical as the incidence of heart attacks is expected to increase with a growing aging population.”
ACTION Registry–GWTG is a partnership between the American College of Cardiology Foundation and the American Heart Association with partnering support from the American College of Emergency Physicians, Society of Chest Pain Centers and the Society of Hospital Medicine. ACTION Registry-GWTG empowers health care provider teams to consistently treat heart attack patients according to the most current, science-based guidelines and establishes a national standard for understanding and improving the quality, safety and outcomes of care provided for patients with coronary artery disease, specifically high-risk STEMI and NSTEMI patients.
